Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery (2020)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- Subjects: BIOQUÍMICA; CIRURGIA; PROSTATECTOMIA; PRÓSTATA; NEOPLASIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Modern Pathology
- ISSN: 1530-0285
- Volume/Número/Paginação/Ano: v. 33, suppl. 2, res. 932, 2020
- Conference titles: USCAP Annual Meeting
-
ABNT
JAMASPISHVILI, Tamara et al. Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery. Modern Pathology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 27 dez. 2025. , 2020 -
APA
Jamaspishvili, T., Patel, P., Niu, Y., Vidotto, T., Ouellet, V., Mes-Masson, A. M., et al. (2020). Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery. Modern Pathology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Jamaspishvili T, Patel P, Niu Y, Vidotto T, Ouellet V, Mes-Masson AM, Lotan T, Squire JA, Peng Y, Siemens D, Berman D. Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery. Modern Pathology. 2020 ; 33[citado 2025 dez. 27 ] -
Vancouver
Jamaspishvili T, Patel P, Niu Y, Vidotto T, Ouellet V, Mes-Masson AM, Lotan T, Squire JA, Peng Y, Siemens D, Berman D. Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery. Modern Pathology. 2020 ; 33[citado 2025 dez. 27 ] - Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- Extracellular vesicles: evolving factors in stem cell biology
- The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
